BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo

BACKGROUND: Tamoxifen (TAM) has been widely used for the treatment of estrogen receptor (ER)-positive breast cancer and its combination with other therapies is being actively investigated as a way to increase efficacy and decrease side effects. Here, we evaluate the therapeutic potential of co-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shujie, Castillo, Victor, Welty, Matt, Alvarado, Mark, Eliaz, Isaac, Temm, Constance J., Sandusky, George E., Sliva, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314617/
https://www.ncbi.nlm.nih.gov/pubmed/28209156
http://dx.doi.org/10.1186/s12906-017-1621-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314617/
https://www.ncbi.nlm.nih.gov/pubmed/28209156
http://dx.doi.org/10.1186/s12906-017-1621-7

Ejemplares similares